Tag: BMS
Tübingen-based biotech company Immatics agrees billion-euro deal with Bristol-Myers
researcher in the laboratory The two companies want to jointly develop up to six cell therapies based on standardized, genetically modified immune cells. (Photo: imago images/Panthermedia) Frankfurt The Tübingen-based biotech…
Evotec seals billion-euro deal with BMS for protein destroyers
Frankfurt With a new deal worth billions, the German biotech company Evotec is expanding its existing alliance with the US pharmaceutical giant Bristol-Myers Squibb (BMS) in the field of “protein…
In the fight against cancer
Frankfurt The fight against the coronavirus has been in the headlines for two years, but there has also been immense progress in the fight against cancer. Because in the long…
Corona tests need a test – Handelsblatt Morning Briefing
Again this week, many Germans will spend their time in the Corona test center or at home with test cassettes (“Where is the line?”). Many need proof of identity for…
In the fight against cancer
Frankfurt The fight against the coronavirus has been in the headlines for two years, but there has also been immense progress in the fight against cancer. Because in the long…
$ 900 million deal with pharmaceutical company BMS
Immatics laboratory in Tübingen The biotech company, founded in 2000, develops novel therapies against cancer. (Photo: Immatics Biotechnologies GmbH) Frankfurt The Tübingen-based biotech company Immatics signs a development and marketing…